Literature DB >> 30259375

Circular RNAs in Vascular Functions and Diseases.

Shengguang Ding1, Yujiao Zhu2,3, Yajun Liang2,3, Haitao Huang1, Yiming Xu1, Chongjun Zhong4.   

Abstract

Vascular disease is one of the top five causes of death and affects a variety of other diseases, such as heart, nervous system, and metabolic disorders. Vascular dysfunction is a hallmark of ischemia, cancer, and inflammatory diseases and can accelerate the progression of diseases. Circular RNAs (circRNAs) are a new type of noncoding RNAs with covalent bond ring structure, which have been reported to be abnormally expressed in many human diseases. circRNAs regulate gene expression through the sponging of microRNAs (miRNAs) and can also be used as disease biomarkers. Here we will summarize the functions of circRNAs in vascular diseases, including vascular dysfunction, atherosclerosis, diabetes mellitus-related retinal vascular dysfunction, chronic thromboembolic pulmonary hypertension, carotid atherosclerotic disease, hepatic vascular invasion in hepatocellular carcinoma, aortic aneurysm, coronary artery disease, and type 2 diabetes mellitus.

Entities:  

Keywords:  Circular RNAs; Vascular diseases; Vascular function

Mesh:

Substances:

Year:  2018        PMID: 30259375     DOI: 10.1007/978-981-13-1426-1_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Extracellular Vesicle-Mediated Vascular Cell Communications in Hypertension: Mechanism Insights and Therapeutic Potential of ncRNAs.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-22       Impact factor: 3.727

2.  Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

3.  Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.

Authors:  Kenneth Maiese
Journal:  Int Rev Neurobiol       Date:  2020-08-11       Impact factor: 3.230

Review 4.  New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2020-06-01

Review 5.  Role of LncRNAs and CircRNAs in Bone Metabolism and Osteoporosis.

Authors:  Suryaji Patil; Kai Dang; Xin Zhao; Yongguang Gao; Airong Qian
Journal:  Front Genet       Date:  2020-11-13       Impact factor: 4.599

Review 6.  MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Hypertens Res       Date:  2020-09-23       Impact factor: 3.872

Review 7.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

8.  LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype.

Authors:  Chengxin Zhang; Shangqing Ge; Wenhui Gong; Jinguo Xu; Zhixiang Guo; Zhuang Liu; Xiaotian Gao; Xiaoyong Wei; Shenglin Ge
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

9.  Circular RNA USP1 regulates the permeability of blood-tumour barrier via miR-194-5p/FLI1 axis.

Authors:  Yang Gao; Peiqi Wu; Yawen Ma; Yixue Xue; Yunhui Liu; Jian Zheng; Xiaobai Liu; Qianru He; Jun Ma; Libo Liu; Ping Wang
Journal:  J Cell Mol Med       Date:  2019-10-26       Impact factor: 5.310

10.  Circular RNA circ_0003204 inhibits proliferation, migration and tube formation of endothelial cell in atherosclerosis via miR-370-3p/TGFβR2/phosph-SMAD3 axis.

Authors:  Shanchao Zhang; Guixiang Song; Jing Yuan; Shan Qiao; Shan Xu; Zhihua Si; Yang Yang; Xuxu Xu; Aihua Wang
Journal:  J Biomed Sci       Date:  2020-01-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.